SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-23-010603
Filing Date
2023-03-29
Accepted
2023-03-29 16:11:23
Documents
75
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K hrtx-20221231.htm   iXBRL 10-K 3316189
2 EX-23.1 hrtx-ex23_1.htm EX-23 6019
3 EX-31.1 hrtx-ex31_1.htm EX-31 20950
4 EX-31.2 hrtx-ex31_2.htm EX-31 20803
5 EX-32.1 hrtx-ex32_1.htm EX-32 12205
  Complete submission text file 0000950170-23-010603.txt   12638733

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hrtx-20221231_lab.xml EX-101.LAB 577554
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hrtx-20221231_cal.xml EX-101.CAL 67262
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hrtx-20221231.xsd EX-101.SCH 58730
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hrtx-20221231_pre.xml EX-101.PRE 398717
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hrtx-20221231_def.xml EX-101.DEF 239717
69 EXTRACTED XBRL INSTANCE DOCUMENT hrtx-20221231_htm.xml XML 2769141
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33221 | Film No.: 23775317
SIC: 2834 Pharmaceutical Preparations